Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,616.85
(
0.08%
)
US TECH 100
24,300.80
(
3.22%
)
Dow Jones
46,584.46
(
-0.18%
)
Brent Oil
92.87
(
-8.25%
)
Bitcoin
71,761.16
(
-0.31%
)
News Focus
News Focus
Post# of 516950
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

georgejjl

Send PM Follow Ignore
Followers 147
Posts 26154
Boards Moderated 0
Alias Born 04/08/2004

georgejjl

Re: Investor2014 post# 485269

Sunday, 03/23/2025 4:53:43 PM

Sunday, March 23, 2025 4:53:43 PM

Post# of 516950
Not at all!!!

It means that the ADL endpoint is only sensitive enough for mild to moderate stage Alzheimer’s disease and not for MCI and/or early stage Alzheimer’s disease.

The OLE study for blarcamesine will show statistical significance of blarcamesine as expected.

GOD bless,
Bullish
Bullish
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News